0 Ratings
ID

26116

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacogenetic research Withdrawal of consent

Keywords

Versions (4)
  1. 10/9/17 10/9/17 -
  2. 10/16/17 10/16/17 -
  3. 10/23/17 10/23/17 -
  4. 1/11/18 1/11/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 9, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Pharmacogenetic research Withdrawal of consent GSK study Chronic Coronary Heart Disease NCT00799903

    English

    Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

    1 forms  
    Withdrawal of consent for PGx (DNA) / Blood sample destruction
    Description

    Withdrawal of consent for PGx (DNA) / Blood sample destruction

    1. Has subject withdrawn consent for PGx research?
    Description

    withdrawal consent for PGx research

    Data type

    boolean

    If subject has withdrawn consent for PGx research: date informed consent withdrawn
    Description

    date informed consent withdrawn

    Data type

    date

    2. Has a request been made for blood sample destruction?
    Description

    request for blood sample destruction

    Data type

    boolean

    If a request has been made for blood sample destruction, check reason
    Description

    request for blood sample destruction reason

    Data type

    text

    If other reason applied, specify
    Description

    request for blood sample destruction other reason

    Data type

    text

    Back to the top of the page

    Similar models

    Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Withdrawal of consent for PGx (DNA) / Blood sample destruction
    withdrawal consent for PGx research
    Item
    1. Has subject withdrawn consent for PGx research?
    boolean
    date informed consent withdrawn
    Item
    If subject has withdrawn consent for PGx research: date informed consent withdrawn
    date
    request for blood sample destruction
    Item
    2. Has a request been made for blood sample destruction?
    boolean
    Item
    If a request has been made for blood sample destruction, check reason
    text
    undefined item
    Code List
    If a request has been made for blood sample destruction, check reason
    CL Item
    Subject withdrew consent for PGx (3)
    CL Item
    Other (Z)
    request for blood sample destruction other reason
    Item
    If other reason applied, specify
    text
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial